PAA 0.00% 19.0¢ pharmaust limited

Ann: AGM Presentation, page-42

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 12,229 Posts.
    lightbulb Created with Sketch. 6234
    This is why regular updates are required from the Company, Monthly News letter would suffice ,, so 3 months don't run away at a time ..
    Next Month December ,,here is December 2020..https://stocknessmonster.com/announcements/paa.asx-6A1013933/

    PharmAust Commences Manufacture of GMP-Grade Monepantel for Human Clinical Trial

    • Monepantel (MPL) to be used in a Phase 1/2 human trial in Motor Neurone Disease (MND), as well as a human Phase 1/2 cancer trial

    • The MND trial, co-funded with FightMND, is scheduled to commence in October 2021

    • Subject to regulatory approvals the cancer trial in humans is scheduled to commence in
    late CY 2021

    • In-house small-scale manufactured MPL demonstrates greater than 2-year shelf-life
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.